SCHEMBL30459865

SCHEMBL30459865

CNC1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
INSR P06213 20/20 0.87
ALK Q9UM73 20/20 0.87
IGF1R P08069 14/20 0.87
AURKA O14965 2/20 0.87
AURKB Q96GD4 2/20 0.87
PLK4 O00444 1/20 0.87
DAPK3 O43293 1/20 0.87
JAK2 O60674 1/20 0.87
MAP4K4 O95819 1/20 0.87
ABL1 P00519 1/20 0.87
NTRK1 P04629 1/20 0.87
PRKCG P05129 1/20 0.87
LCK P06239 1/20 0.87
FYN P06241 1/20 0.87
CSF1R P07333 1/20 0.87
LYN P07948 1/20 0.87
RET P07949 1/20 0.87
MET P08581 1/20 0.87
ROS1 P08922 1/20 0.87
KIT P10721 1/20 0.87

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25272952 1.00 INSR (0.87) INSRALKIGF1RAURKAAURKB
SCHEMBL23635199 0.94 INSR (0.87) INSRALKIGF1RAURKAAURKB
SCHEMBL25397352 0.94 INSR (0.86) INSRALKIGF1RAURKAAURKB
SCHEMBL30170709 0.94 INSR (0.86) INSRALKIGF1RAURKAAURKB
Entrectinib SCHEMBL3512601 0.93 INSR (1.00) INSRALKIGF1RAURKAAURKB
Entrectinib SCHEMBL29394152 0.93 INSR (1.00) INSRALKIGF1RAURKAAURKB
Entrectinib SCHEMBL29358922 0.93 INSR (1.00) INSRALKIGF1RAURKAAURKB
SCHEMBL26275691 0.93 INSR (0.88) INSRALKIGF1RAURKAAURKB
SCHEMBL3511237 0.92 INSR (0.83) INSRALKIGF1RAURKAAURKB
SCHEMBL3511228 0.92 INSR (1.00) INSRALKIGF1RAURKAAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023104155-A1 LIGAND COMPOUNDS FOR E3 UBIQUITIN LIGASE, PROTEIN DEGRADERS DEVELOPED ON BASIS OF LIGAND COMPOUNDS, AND USES THEREOF 标新生物医药科技(上海)有限公司 2023-06-15 WO disclosed